重症患者常规与按需采血的系统评价
该系统评价检索了 Cochrane Library、Excerpta Medica Database 和 Medical Literature Analysis and Retrieval Online 至 2022 年 9 月,纳入 70 项研究(50 项非随机干预研究、20 项观察性研究)。常规采血暴露比例为 52%-100%(证据确定性极低);内科重症监护环境中采血似乎更频繁,中位数每患者每日 18 次(四分位距 10-33)(证据确定性极低);混合生化检查似乎是所有环境中最常进行的采血项目(每患者每日 5 次,四分位距 2-10)(证据确定性极低)。减少常规采血似乎与输血率和费用降低相关,且无明显的患者不良结局(证据确定性低)。
要点
- 常规采血暴露比例为 52%-100%,证据确定性极低。
- 内科重症监护环境中采血似乎更频繁,中位数每患者每日 18 次(IQR 10-33)。
- 混合生化检查似乎是最常进行的项目,每患者每日 5 次(IQR 2-10)。
- 减少常规采血似乎与输血率和费用降低相关,无 apparent 不良结局(证据确定性低)。
适用人群与场景
- 重症患者,包括内科重症监护环境中的患者。
研究设计与关键结果
- 系统评价纳入 70 项研究:50 项非随机干预研究和 20 项观察性研究。
- 常规采血暴露比例为 52%-100%(证据确定性极低)。
- 内科重症监护环境中采血似乎更频繁,中位数每患者每日 18 次(四分位距 10-33)(证据确定性极低)。
- 混合生化检查似乎是所有环境中最常进行的采血项目,每患者每日 5 次(四分位距 2-10)(证据确定性极低)。
- 减少常规采血似乎与输血率和费用降低相关,无明显的患者不良结局(证据确定性低)。
证据类型、等级与局限
- 证据类型:系统评价,纳入 50 项非随机干预研究和 20 项观察性研究。
- 证据确定性:常规采血暴露比例、采血频率和混合生化检查频率的证据确定性极低;减少常规采血与输血率和费用降低相关的证据确定性低。
- 局限:原文未报告局限性。
对床旁实践的改变
- 减少常规采血似乎与输血率和费用降低相关且无明显不良结局,但证据很不确定。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to provide an overview of the current evidence on routine versus on-demand blood sampling in critical care. We assessed the reported proportion of patients exposed to daily routine blood sampling, the tests performed, characteristics associated with more frequent blood sampling, and the reported benefits and harms of routine blood sampling compared with on-demand sampling.
DATA SOURCES: We systematically searched the Cochrane Library, the Excerpta Medica Database, and the Medical Literature Analysis and Retrieval System Online for studies assessing routine versus on-demand blood testing in critically ill patients from inception to September 2022.
STUDY SELECTION: Abstracts and full texts were assessed independently and in duplicate by two reviewers.
STUDY EXTRACTION: Data were extracted independently and in duplicate by two reviewers using predefined extraction forms.
DATA SYNTHESIS: Of 12,212 records screened, 298 full-text articles were assessed for eligibility. We included 70 studies; 50 nonrandomized interventional studies and 20 observational studies. Exposure to routine blood testing was 52-100% (very low certainty of evidence). Blood testing seemed to occur more frequently in medical intensive care settings with a median of 18 blood tests per patient day (interquartile range, 10-33) (very low certainty of evidence). Mixed biochemistry seemed to be the most frequently performed blood tests across all settings (five tests per patient day; interquartile range, 2-10) (very low certainty of evidence). Reductions in routine blood testing seemed to be associated with reduced transfusion rates and costs without apparent adverse patient outcomes (low certainty of evidence).
CONCLUSIONS: In this systematic review, routine blood testing in critically ill patients was common and varied considerably. A reduction in routine blood testing appeared to be associated with reduced transfusion rates and costs without adverse effects, but the evidence was very uncertain.
参考来源
- Hjortsø CJS, Møller MH, Perner A, et al. Routine Versus On-Demand Blood Sampling in Critically Ill Patients: A Systematic Review. Crit Care Med. 2023. PMID: 36951465. doi:10.1097/CCM.0000000000005852
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。